Close
Achema middle east

Yuvraj

Biotie: BTT1023 receives Orphan Drug Designation in the United States

The United States Food and Drug Administration (FDA) has granted Orphan Drug Designation in the United States for Biotie's BTT1023 drug candidate for the...

Denali Therapeutics Announces First Clinical Trial Application, Key Collaborations And $130M Series B

Denali Therapeutics Inc announced several critical milestones in the company's growth, including its first Clinical Trial Application to initiate a Phase 1 trial, previously...

Klöckner Pentaplast will display latest range of packaging solutions at Agroprodmash 2016

Klöckner Pentaplast will present the latest range of packaging solutions at Agroprodmash, 10-14 October in Moscow, Russia. Focusing on the recently awarded clikPET packaging...

Mylan Invalidates Two of Teva’s Copaxone® 40 mg/mL Patents Via U.S. Patent and Trademark Office

Mylan N.V. announced that the U.S. Patent and Trademark Office (PTO) has ruled in favor of Mylan in its inter partes review (IPR) proceeding...

TaiGen Biotechnology Out-Licenses Taigexyn® (Nemonoxacin) to Productos Científicos for the Latin American Market

TaiGen Biotechnology Company, Limited announced that they have signed an exclusive licensing agreement with Productos Científicos S.A. de C.V. ("PC"), a leading Mexican pharmaceutical...

Nymox Pharmaceutical Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results

Nymox Pharmaceutical Corp is pleased to announce successful new study results from the long-term blinded placebo crossover group from the U.S. Phase 3 trials...

Ball Corporation Publishes 2016 Sustainability Report

Ball Corporation published its fifth biennial sustainability report, which details the company's progress toward its updated priorities – product stewardship, operational excellence, talent management...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »